Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.69
Delayed Data
As of Sep 23
 +0.25 / +2.96%
Today’s Change
5.57
Today|||52-Week Range
10.95
-19.46%
Year-to-Date

Today’s Trading

Previous close8.44
Today’s open8.71
Day’s range8.54 - 9.19
Volume4,856,974
Average volume (3 months)1,440,392
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,463.25%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratio79.0
Price/Sales20.49
Price/Book2.64

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.47-1.36%
EBSEmergent BioSolution...-0.38-1.32%
AERIAerie Pharmaceutical...+1.02+2.68%
ACORAcorda Therapeutics ...+0.06+0.22%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

Search for Jobs